Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 11;6(1):26.
doi: 10.1038/s41541-021-00290-y.

Promoting versatile vaccine development for emerging pandemics

Joshua T Monrad  1   2   3 , Jonas B Sandbrink  4   5 , Neil G Cherian  6   7
Affiliations
Review

Promoting versatile vaccine development for emerging pandemics

Joshua T Monrad et al. NPJ Vaccines. .

Abstract

The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccine development, and outline how previous pathogen-specific funding approaches can be improved to adequately promote vaccine R&D for emerging pandemics. We present a more comprehensive approach to financing vaccine R&D, which maximises biomedical pandemic preparedness by promoting flexible vaccine platforms and translatable research into prototype pathogens. As the numerous platform-based SARS-CoV-2 vaccines show, funders can accelerate pandemic vaccine development by proactively investing in versatile platform technologies. For certain emerging infectious diseases, where vaccine research can translate to other related pathogens with pandemic potential, investment decisions should reflect the full social value of increasing overall preparedness, rather than just the value of bringing a vaccine to market for individual pathogens.

PubMed Disclaimer

Conflict of interest statement

N.G.C. is a Scientific Officer at the Coalition of Epidemic Preparedness Innovations. J.T.M. and J.B.S. declare no competing interests.

References

    1. Wolf J, et al. Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens. npj Vaccines. 2020;5:1–5. doi: 10.1038/s41541-020-0204-7. - DOI - PMC - PubMed
    1. Hoyt K, Hatchett R. Preparing for the next Zika. Nat. Biotechnol. 2016;34:384–386. doi: 10.1038/nbt.3532. - DOI - PMC - PubMed
    1. Adalja, A. A., Watson, M., Toner, E., Cicero, A. & Inglesby, T. The Characteristics of Pandemic Pathogens. https://www.centerforhealthsecurity.org/our-work/publications/the-charac... (2018).
    1. Marston HD, Paules CI, Fauci AS. The critical role of biomedical research in pandemic preparedness. JAMA. 2017;318:1757–1758. doi: 10.1001/jama.2017.15033. - DOI - PubMed
    1. Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat. Immunol. 2018;19:20–28. doi: 10.1038/s41590-017-0007-9. - DOI - PMC - PubMed